C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2011
08/18/2011	WO2011100286A2 Compositions and methods of generating a differentiated mesodermal cell
08/18/2011	WO2011099783A9 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof
08/18/2011	WO2011099783A2 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof
08/18/2011	WO2011099721A2 Composition for inducing the maturation of dendritic cells
08/18/2011	WO2011099528A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
08/18/2011	WO2011098516A1 Improved composition for inhibiting tumor cell proliferation
08/18/2011	WO2011098497A1 Zeolite membrane for cellular adhesion, growth and cultures and process for preparation thereof
08/18/2011	WO2011098053A1 Use of galectins and method of preparation of myofibroblasts and/or extracellular matrix nanofibers
08/18/2011	WO2011063413A3 Herbicide tolerant soybean plants and methods for identifying same
08/18/2011	WO2011056416A3 Cardiomyocyte production
08/18/2011	WO2011053257A3 Methods for monitoring cellular states and for immortalizing mesenchymal stem cells
08/18/2011	WO2011031875A9 Cell-based compositions and uses thereof
08/18/2011	WO2011011300A8 Differentiation of human embryonic stem cells
08/18/2011	WO2007147004A3 Differentiation of multi-lineage progenitor cells to hepatocytes
08/18/2011	US20110203019 Methods of producing gaba
08/18/2011	US20110203017 Novel Herbicide Resistance Genes
08/18/2011	US20110203015 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE
08/18/2011	US20110203014 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use
08/18/2011	US20110203013 Delivering compositions of interest to plant cells
08/18/2011	US20110203011 Methods and compositions for producing aluminum tolerant alfalfa
08/18/2011	US20110203010 Insect-derived promoters for foreign proteins expression in insect cells
08/18/2011	US20110203009 Method for producing glycoprotein characterized by sugar chain structure by using silkworm
08/18/2011	US20110203008 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof
08/18/2011	US20110202479 Recognition sequences for i-crei-derived meganucleases and uses thereof
08/18/2011	US20110201788 Hybridoma producing antibodies to lawsonia intracellularis
08/18/2011	US20110201787 Hybridoma producing antibodies to lawsonia intracellularis
08/18/2011	US20110201786 Hybridoma producing antibodies to lawsonia intracellularis
08/18/2011	US20110201691 Modulation of fibroblast activity
08/18/2011	US20110201686 Inhibitors of ASS and Synuclein Aggregation
08/18/2011	US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same
08/18/2011	US20110201671 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus
08/18/2011	US20110201667 Compositions and methods for silencing ebola virus gene expression
08/18/2011	US20110201610 Aryl sulfonamides
08/18/2011	US20110201609 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
08/18/2011	US20110201599 CDK Modulators
08/18/2011	US20110201594 Pyrido [2,3-d] pyrimidines and their use as kinase inhibitors
08/18/2011	US20110201592 Therapeutic Oxy-Phenyl-Aryl Compounds and Their Use
08/18/2011	US20110201576 Small molecule inhibitors of stat3 with anti-tumor activity
08/18/2011	US20110201569 Methods For Treating Myocardial Disorders
08/18/2011	US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein
08/18/2011	US20110201544 Compositions and Methods for Inhibiting the Interaction between CFTR and CAL
08/18/2011	US20110201119 Alphavirus packaging cell lines
08/18/2011	US20110201118 Nuclease activity of tal effector and foki fusion protein
08/18/2011	US20110201117 Forming porous scaffold from cellulose derivatives
08/18/2011	US20110201116 Test method using cells and test kit therefor
08/18/2011	US20110201115 Method and apparatus for production of a skin graft and the graft produced thereby
08/18/2011	US20110201114 Manufacturing Method of Immune Killer Cells
08/18/2011	US20110201113 Ex Vivo Progenitor and Stem Cell Expansion and Differentiation for Use in the Treatment of Disease of the Nervous System
08/18/2011	US20110201112 Vault Complexes for Facilitating Biomolecule Delivery
08/18/2011	US20110201111 Method for obtaining connective mesenchymal stem cells from the mononuclear fraction of human bone marrow
08/18/2011	US20110201110 Efficient method for establishing induced pluripotent stem cells
08/18/2011	US20110201109 Ronin is Essential for Perpetuity of Mouse ES Cells, and Acts Independently of Canonical Pathways
08/18/2011	US20110201108 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
08/18/2011	US20110201107 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
08/18/2011	US20110201106 Devices and methods for tissue handling and embedding
08/18/2011	US20110201105 Lactation-associated polypeptides
08/18/2011	US20110201104 Antiviral agent against animal viruses
08/18/2011	US20110201087 Compositions and Methods for the Production of Alpha-Herpesviruses
08/18/2011	US20110201081 Buttiauxella Sp. Phytase Variants
08/18/2011	US20110201078 Ligand functionalized polymers
08/18/2011	US20110201075 Optoinjection methods
08/18/2011	US20110201053 Recombinant Expression Vector Elements (REVES) for Enhancing Expression of Recombinant Proteins in Host Cells
08/18/2011	US20110201052 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
08/18/2011	US20110201051 Chemosensory gene family encoding gustatory and olfactory receptors and uses thereof
08/18/2011	US20110201043 Transgenic mammals and cell lines for the identification of glutamate transporter modulators
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110201028 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/18/2011	US20110201023 Mannose 6-phosphate-binding antibodies and their uses
08/18/2011	US20110201021 Use of the irap protein for implementing methods of diagnosis and of prognosis
08/18/2011	US20110201020 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/18/2011	US20110201003 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200987 Compositions and methods for modifying cellular properties
08/18/2011	US20110200629 Tumor antigen peptide and use thereof
08/18/2011	US20110200627 Anti-cd147 antibodies, methods and uses
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200624 Novel peptides for use in transfection
08/18/2011	US20110200622 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
08/18/2011	US20110200614 Anthrax specific antibodies
08/18/2011	US20110200608 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200602 Antibodies to egfl7 and methods for their use
08/18/2011	US20110200596 Monovalent antibody fragments useful as therapeutics
08/18/2011	US20110200594 Functionalized polypeptides
08/18/2011	US20110200585 Cd127 binding proteins
08/18/2011	US20110200584 Method to stimulate immune function and regeneration
08/18/2011	US20110200579 Novel gene disruptions, compositions and methods relating thereto
08/18/2011	US20110200576 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
08/18/2011	US20110200568 Induced pluripotent stem cells
08/18/2011	US20110200567 Methods and compositions for the treatment of lung diseases and disorders
08/18/2011	US20110200566 Compositions and Methods for the Treatment of Vitiligo
08/18/2011	US20110200565 Virus clearance of neoplastic cells from mixed cellular compositions
08/18/2011	US20110200562 Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use
08/18/2011	US20110200560 Non-ionic self-assembling peptides and uses thereof
08/18/2011	US20110200559 Method for production of three-dimensional structure of cells
08/18/2011	US20110200552 Cytokine design
08/18/2011	CA2789852A1 Media, kits, systems and methods for the micropropagation of bamboo
08/18/2011	CA2789454A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
08/17/2011	EP2357464A1 Apparatus and methods for providing sex-sorted animal sperm
08/17/2011	EP2357250A2 Production of polypeptides

1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 1827